NCT Number,Study Title,Study URL,Acronym,Study Status,Brief Summary,Study Results,Conditions,Interventions,Primary Outcome Measures,Secondary Outcome Measures,Other Outcome Measures,Sponsor,Collaborators,Sex,Age,Phases,Enrollment,Funder Type,Study Type,Study Design,Other IDs,Start Date,Primary Completion Date,Completion Date,First Posted,Results First Posted,Last Update Posted,Locations,Study Documents
NCT00072761,Silent Cerebral Infarct Transfusion Multi-Center Clinical Trial,https://clinicaltrials.gov/study/NCT00072761,SIT,COMPLETED,The goal of this study is to determine the effectiveness of blood transfusion therapy for prevention of silent cerebral infarct (stroke) in children with sickle cell anemia.,YES,Sickle Cell Anemia|Stroke,PROCEDURE: transfusion therapy,"Recurrence of an Infarct, Defined as a Stroke or a New or Enlarged Silent Cerebral Infarct, The primary end point was the recurrence of infarct or hemorrhage as determined by neuroimaging, clinical evidence of permanent neurologic injury, or both. A new infarct had to meet the criteria for a silent cerebral infarction; an enlarged silent cerebral infarct was defined as a previously identified silent cerebral infarct that increased by at least 3 mm along any linear dimension in any plane on MRI., From study entry to study exit",,,Washington University School of Medicine,National Institute of Neurological Disorders and Stroke (NINDS),ALL,CHILD,PHASE3,196,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (INVESTIGATOR)|Primary Purpose: TREATMENT,R01NS42804|5U01NS042804-07,2004-12,2013-12,2013-12,2003-11-13,2016-02-08,2016-02-08,"Washington University School of Medicine, St. Louis, Missouri, 63110, United States",
